CVE-2025-12921
Openclinica 3.12.2 … 3.13
Raw vector
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:XCVSS and EPSS are reproduced from their sources (NVD, FIRST EPSS). Risk Priority is our own derived reading, not an NVD score.
Summary
CVE-2025-12921 is a low-severity Injection (CWE-74) vulnerability in Openclinica Openclinica. Its CVSS base score is 2.1 (Low).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked at the 42th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
The strongest mitigations our analysis identified map to SI-10 (Information Input Validation) — see the control section below for these in your framework.
OWASP Top 10 for Web (2025)
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2025-38721
Vulnerability Data
A vulnerability has been found in OpenClinica Community Edition up to 3.12.2/3.13. Affected by this issue is some unknown functionality of the file /ImportCRFData?action=confirm of the component CRF Data Import. Such manipulation of the argument xml_file leads to xml injection.…
more
It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise Techniques
CVEs Like This One
Affected Assets
Mitigating Controls
Control response
—
—
—
V1.2.1V1.2.3V1.2.5V1.2.8
Mitigating Controls (NIST 800-53 r5) AI
SI-10 directly requires validation of information inputs to reject malformed or special-element content before it reaches downstream parsers.
Mitigating Controls (NIST CSF 2.0) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→CSF cross-walk (authority under review) — links open the control.
Secure SDLC practices directly require input validation and output encoding that prevent injection flaws.
Mitigating Controls (ISO/IEC 27001:2022 Annex A) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→ISO cross-walk (authority under review) — links open the control.
Security testing in development catches injection vulnerabilities before release.
Logging supports detection of injection attempts but does not prevent the weakness.
Monitoring activities can identify active injection attacks after they occur.
Secure development life cycle mandates input validation and output encoding that directly prevent injection flaws.
Application security requirements explicitly call for controls against injection attacks in software design.
Secure architecture principles reduce injection surfaces but do not prescribe specific neutralization techniques.